The effect of statin therapy in combination with ezetimibe on circulating C-reactive protein levels: a systematic review and meta-analysis of randomized controlled trials

被引：0

作者：

Seyyed Mostafa Arabi

Mahla Chambari

Mahsa Malek-Ahmadi

Leila Sadat Bahrami

Vahid Hadi

Manfredi Rizzo

Amirhossein Sahebkar

机构：

[1] Neyshabur University of Medical Sciences,Noncommunicable Diseases Research Center

[2] Neyshabur University of Medical Sciences,Department of Basic Sciences

[3] AJA University of Medical Sciences,Department of Nutrition and Biochemistry, Faculty of Medicine

[4] Mashhad University of Medical Sciences,Metabolic Syndrome Research Center, Department of Nutrition, School of Medicine

[5] Varastegan Institute for Medical Sciences,Department of Nutrition Sciences

[6] Imam Khomeini Hospital Complex,Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics

[7] Tehran University of Medical Sciences,Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (Promise), School of Medicine

[8] Tehran University of Medical Sciences,Applied Biomedical Research Center

[9] University of Palermo,Biotechnology Research Center, Pharmaceutical Technology Institute

[10] Mashhad University of Medical Sciences,School of Medicine

[11] Mashhad University of Medical Sciences,Department of Biotechnology, School of Pharmacy

[12] The University of Western Australia,undefined

[13] Mashhad University of Medical Sciences,undefined

来源：

Inflammopharmacology | 2022年 / 30卷

关键词：

Statins; Atherosclerosis; Inflammation; CRP;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1597 / 1615

页数：18

共 880 条

[1]

Almquist T(2012)Effects of lipid-lowering treatment on platelet reactivity and platelet-leukocyte aggregation in diabetic patients without and with chronic kidney disease: a randomized trial Nephrol Dial Transplant 27 3540-3546

[2]

Jacobson SH(2008)Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study Clin Ther 30 84-97

[3]

Lins PE(2017)Preoperative statins as modifiers of cardiac and inflammatory outcomes following coronary artery bypass graft surgery: a meta-analysis Interact Cardiovasc Thorac Surg 25 958-965

[4]

Farndale RW(2022)Impact of walnut consumption on cardio metabolic and anthropometric parameters in metabolic syndrome patients: GRADE-assessed systematic review and dose-response meta-analysis of data from randomized controlled trials Pharmacol Res 178 1-5

[5]

Hjemdahl P(2022)Impact of synbiotic supplementation on cardiometabolic and anthropometric indices in patients with metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials Pharmacol Res 176 516-524

[6]

Alvarez-Sala LA(2010)Pleiotropic effects with equivalent low-density lipoprotein cholesterol reduction: comparative study between simvastatin and simvastatin/ezetimibe coadministration J Cardiovasc Pharmacol 55 111-118

[7]

Cachofeiro V(2016)Clinical relevance for lowering C-reactive protein with statins Ann Med 48 1571-1574

[8]

Masana L(2012)Comparison of the efficacy and safety of statin and statin/ezetimibe therapy after coronary stent implantation in patients with stable angina J Cardiol 60 670-682

[9]

Suarez C(2011)Comparison of the effects of combination atorvastatin (40 mg) + ezetimibe (10 mg) versus atorvastatin (40 mg) alone on secretory phospholipase A2 activity in patients with stable coronary artery disease or coronary artery disease equivalent Am J Cardiol 107 2409-2415

[10]

Pinilla B(2003)Effects of statins on nonlipid serum markers associated with cardiovascular disease: a systematic review Ann Intern Med 139 673-680

← 1 2 3 4 5 6 7 8 9 10 →